查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1624373

微生物组定序服务市场按技术、实验室类型、研究类型、应用、最终用户和地区划分，2024 年至 2031 年

Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis, Sequencing By Ligation, Pyrosequencing, Sanger Sequencing), By Laboratory Type, By Research Type, By Application, By End-User, And Region For 2024- 2031
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

微生物组定序服务市场评估，2024-2031

个人化医疗需求的日益增长、测序技术的进步以及对微生物组在人类健康和疾病中的作用的不断加深的理解，正在推动微生物组测序服务市场的发展。根据 Verified Market Research 分析师的预测，微生物组定序服务市场规模预计将在 2023 年超过约 16.3 亿美元，并在 2031 年预测期内达到 40 亿美元的估值。

对微生物组在疾病预防、诊断和治疗中的作用的认识不断提高，以及学术界和生物技术之间日益增长的合作，进一步推动了市场的发展。这将使市场从 2024 年到 2031 年的复合年增长率达到 11.87%。

微生物组定序服务市场定义/概述

微生物组定序服务是利用高通量定序技术检测和分析特定环境（如人体或土壤）中微生物遗传物质的过程。该服务提供了对微生物群落的结构和功能的精确洞察，从而能够更深入地瞭解微生物在健康和疾病中的作用。

此外，微生物组定序在医疗保健领域有广泛的应用，包括研究微生物组对发炎性肠道疾病、肥胖症和糖尿病等疾病的影响，最终转化为个人化医疗。它们在农业研究中也发挥着重要作用，可以分析土壤微生物组以提高作物产量，在环境科学中，可以评估不同生态系统中微生物多样性和功能。

高通量定序技术的进步会影响微生物组定序服务市场的成长吗？

包括次世代定序（NGS）在内的高通量定序技术的快速改进，提高了微生物基因组定序的速度和准确性，同时降低了成本。这项技术进步使得微生物组定序更加容易取得并适用于各种学术和治疗应用，从而增加了对这些服务的需求。

微生物组定序的应用范围不仅限于人类健康，还包括农业、环境科学和製药业。在医疗保健领域，微生物组定序被用于实现个人化医疗、改善诊断方法和发现新的治疗方法。在农业方面，它可以帮助改善土壤健康、提高作物产量，并瞭解植物与微生物的相互作用。在许多领域不断扩大的应用范围正在刺激微生物组定序服务市场的扩张。

此外，人们对研究人类微生物组及其在健康和疾病中的作用的兴趣日益浓厚。该领域的研究使人们瞭解了微生物群在多种疾病中的作用，包括肥胖、糖尿病、自体免疫疾病甚至精神健康问题。人们对微生物组研究的日益重视促使对精确分析微生物群落的定序服务的需求激增。

对熟练专业人员的需求将如何影响微生物组定序服务市场？

分析和解释产生的大量数据的复杂性是微生物组定序服务市场的主要障碍之一。微生物族群的多样性及其在不同环境或宿主中的相互作用使得数据分析特别具有课题性。这种复杂性需要先进的生物资讯工具和经验，这为没有内部能力或无法使用现代分析平台的研究人员和公司带来了障碍，从而限制了市场扩张。

微生物组研究缺乏样本收集、DNA提取、定序协议和资料处理的标准化程序。这种不可预测性使得跨研究和跨提供者复製或比较结果变得困难。缺乏全球公认的标准和方法使得评估和比较研究结果变得困难，而这对于推进研究和开发基于微生物组的应用以及加速商业应用至关重要。

目录

第 1 章全球微生物组定序服务市场：简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第 4 章全球微生物组定序服务市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析
  • 监理框架

第5章全球微生物定序服务市场（依最终用户划分）

  • 概述
  • 製药和生技公司
  • 学术和研究机构
  • 其他
第6章 全球微生物组定序服务市场（依应用）
  • 概述
  • 散弹鎗定序 标靶基因定序 RNA定序 全基因组定序
  • 其他
第7章全球微生物定序服务市场（依技术划分）
  • 概述 边合成边定序（SBS） 连接定序 (SBL)
  • 焦磷酸定序
  • 桑格定序
  • 其他
第8章 全球微生物组定序服务市场（依实验室类型）
  • 概述
  • 湿实验室
  • 干燥实验室

第9章全球微生物组定序服务市场（依研究类型）

  • 概述
  • 外包
  • 内部

第10章全球微生物组定序服务市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第 11 章全球微生物组定序服务市场的竞争格局

  • 概述
  • 各公司的市占率
  • 供应商概况
  • 主要发展策略

第 12 章 公司简介

  • Charles River Laboratories
  • Eurofins Scientific
  • BGI
  • CosmosID
  • Microba
  • QIAGEN
  • Microbiome Insights
  • BaseClear
  • CD Genomics
  • Zymo Research

第 13 章 重大进展

  • 产品发布/开发
  • 合併和收购
  • 业务扩展
  • 伙伴关係和合作关係

第 14 章附录

  • 相关研究
简介目录
Product Code: 24061

Microbiome Sequencing Services Market Valuation - 2024-2031

The growing need for personalized medicine, advancements in sequencing technologies, and a greater comprehension of the microbiome's role in human health and disease are driving the market for microbiome sequencing services. According to the analyst from Verified Market Research, the Microbiome Sequencing Services Market is estimated to reach a valuation of USD 4 Billion over the forecast period 2031, subjugating around USD 1.63 Billion valued in 2023.

A growing understanding of the role of the microbiome in disease prevention, diagnosis, and treatment and the growth of academic-biotech partnerships, are further factors driving the market. It enables the market to grow at a CAGR of 11.87% from 2024 to 2031.

Microbiome Sequencing Services Market: Definition/Overview

Microbiome sequencing services are the process of detecting and analyzing the genetic material of microorganisms found in a specific environment, such as the human body or soil, using high-throughput sequencing technologies. This service gives precise insights into the structure and function of microbial communities, allowing for a better understanding of their roles in health and illness.

Furthermore, microbiome sequencing has a wide range of applications, including healthcare, where it is used to examine the impact of the microbiome on disorders such as inflammatory bowel disease, obesity, and diabetes, ultimately leading to personalized medication. It also plays an important role in agricultural research, analyzing soil microbiomes to increase crop productivity, and in environmental science, assessing microbial diversity and function in various ecosystems.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Advancements in High-throughput Sequencing Technologies Influence the growth of the Microbiome Sequencing Services Market?

Rapid improvements in high-throughput sequencing technologies, including Next-Generation Sequencing (NGS), have reduced the cost of microbial genome sequencing while increasing its speed and accuracy. This technical advancement has made microbiome sequencing more accessible and possible for a variety of academic and therapeutic applications, resulting in increased demand for these services.

Microbiome sequencing has applications beyond human health, such as agriculture, environmental science, and pharmaceuticals. In healthcare, microbiome sequencing is used to produce personalized medicine, improve diagnostic methods, and create novel therapeutic tactics. In agriculture, it aids in improving soil health, crop output, and understanding plant-microbe interactions. This growing number of applications in many sectors has fueled the expansion of the Microbiome Sequencing Services Market.

Furthermore, there is a rising interest in examining the human microbiome and its role in health and disease. Research in this field has helped us understand the function of the microbiome in a variety of disorders, including obesity, diabetes, autoimmune diseases, and even mental health difficulties. This increased emphasis on microbiome research has resulted in a surge in demand for sequencing services to precisely analyze microbial communities.

How will Need for Highly Skilled Professionals Favor Microbiome Sequencing Services Market?

The complexity of analyzing and interpreting the enormous volumes of data generated is one of the major obstacles to the Microbiome Sequencing Services Market. Data analysis is especially difficult due to the diversity of microbial populations and their interactions in various settings or hosts. This complexity demands sophisticated bioinformatics tools and experience, which creates an obstacle for researchers and enterprises without in-house capabilities or access to modern analytical platforms, limiting the market's expansion.

Microbiome research lacks standardized procedures for sample collection, DNA extraction, sequencing protocols, and data processing. This unpredictability makes it difficult to reproduce and compare results across studies and providers. The lack of globally acknowledged standards and methodologies makes it challenging to evaluate and compare findings, proving crucial for furthering research and developing microbiome-based applications and inhibiting commercial adoption.

Category-wise Acumens

How Does the Dominance of the Sequencing by Synthesis (SBS) Technology Impact the Market?

According to VMR analyst, the sequencing by synthesis (SBS) segment is expected to dominate the segment within the Microbiome Sequencing Services Market. SBS technology, as represented by Next-Generation Sequencing (NGS) platforms such as Illumina's sequencing systems, has high-throughput capabilities, allowing for the simultaneous sequencing of millions of DNA molecules. This efficiency is critical for microbiome sequencing, which involves analyzing complex and diverse microbial communities. This capacity to process huge volumes of samples rapidly and efficiently is a key reason for SBS's dominant position in the market.

SBS technology ensures excellent precision and reliability in sequencing findings. It has a lower error rate than other sequencing technologies, which is important when identifying and measuring microbial species in a community. The great quality of SBS technology allows researchers and physicians to make educated judgements based on accurate and dependable data, contributing to its widespread adoption.

Furthermore, although the initial investment in SBS technology can be large, the per-sample cost of sequencing has dramatically lowered over the years as SBS technology has advanced and the market has become more competitive. This cost reduction has made SBS more accessible to a wider group of researchers and institutions, allowing for more comprehensive and diverse microbiome research programmes. SBS's low cost, combined with its high throughput and accuracy, make it an appealing choice for microbiome sequencing services.

How Does Access to Advanced Technologies Contribute to the Dominance of Outsourced Segment?

The outsourced segment is estimated to hold the largest share of the Microbiome Sequencing Services Market during the forecast period. Outsourcing microbiome sequencing enables research organizations and businesses to leverage cutting-edge sequencing technologies and bioinformatics tools without incurring significant equipment and training costs. Service providers specialize in sequencing and have the experience and infrastructure to manage complicated projects, which can dramatically enhance sequencing quality and speed. This access is especially useful for small and medium-sized businesses and academic institutions that may lack the means to operate cutting-edge sequencing facilities in-house.

Furthermore, outsourced microbiome sequencing services provide greater flexibility and scalability than internal capabilities. Service providers can readily scale their operations up or down to meet the demands and specific needs of their clients, accommodating everything from tiny exploratory investigations to large-scale sequencing initiatives. This scalability enables research organizations to respond swiftly to changing project scopes and research goals, rather than being constrained by the capacity of their internal facilities.

Country/Region-wise Acumens

How will Demand for Microbiome Sequencing Services in North America Influence the Market?

According to VMR Analysis, the North American region is estimated to dominate in Microbiome Sequencing Services Market during the forecast period. North America is at the forefront of implementing advanced technology, such as next-generation sequencing (NGS), which is essential for microbiome sequencing. The region's openness to incorporate new technology into research and clinical practices improves its ability to perform large-scale microbiome studies, increasing in demand for sequencing services. The existence of leading sequencing technology businesses and startups in North America reinforces this trend.

Furthermore, in North America, there is a rising recognition of the microbiome's significance in health, illness, and environmental applications. This understanding is evident in the increased use of microbiome sequencing in a variety of disciplines, including healthcare, pharmaceuticals, agriculture, and environmental science. For example, in healthcare, there is a considerable emphasis on creating microbiome-based diagnostics, treatments, and personalized medicine. This broad application scope promotes demand for microbiome sequencing services, supporting regional market growth.

Will the Asia Pacific Propel the Demand for Microbiome Sequencing Services?

Asia Pacific is expected to grow at the highest CAGR in the Microbiome Sequencing Services Market during the forecast period. Countries in the Asia Pacific region, particularly China, Japan, South Korea, and Australia, are investing heavily in biotechnology R&D. This includes funding for the development of research infrastructure, including cutting-edge laboratories and sequencing facilities, as well as support for biotech firms and academic microbiome research programs. These investments are laying a solid platform for microbiome research and sequencing services, hence boosting market expansion.

Furthermore, the importance of the microbiome in human health, nutrition, and illness is becoming more widely recognized in Asia Pacific. This increased awareness is generating interest and research in fields such as probiotics, personalized medicine, and microbiome-based therapeutics. The rising prevalence of chronic diseases in the region, which may be connected to microbial imbalances is driving research activities and demand for sequencing services to better understand and treat these conditions.

Competitive Landscape

The competitive landscape of the Microbiome Sequencing Services Market is marked by fierce competition among firms seeking to develop and broaden their offerings. Partnerships, collaborations, and acquisitions are also frequent tactics used by businesses to boost their market position, broaden their geographic reach, and improve their service offering.

Some of the prominent players operating in the Microbiome Sequencing Services Market include:

Charles River Laboratories, Eurofins Scientific, BGI, CosmosID, Microba, QIAGEN, Microbiome Insights, BaseClear, CD Genomics, Zymo Research, OraSure Technologies, MR DNA, Eremid Genomic Services, Clinical-Microbiomics A/S, Novogene Co., EzBiome, Boster Biological Technology, Zifo, Macrogen.

Latest Developments:

In May 2023, CosmosID presented new findings on the gut microbiome and its relationship with chronic inflammatory disorders at the American Gastroenterological Association (AGA) meeting.

In February 2023, Charles River Laboratories announced a collaboration with Danone Nutricia Research to create a microbiome research centre focusing on early-life nutrition and gut health.

In January 2024, Eurofins Scientific acquired LabWest, an Australian contract research organization (CRO), boosting its service offerings in Asia-Pacific, including microbiome testing.

In December 2023, BGI announced its new metagenomics sequencing tool, MGseq-1000, which provides researchers with a faster and more cost-effective choice for microbiome investigation.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MICROBIOME SEQUENCING SERVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY END USER

  • 5.1 Overview
  • 5.2 Pharmaceutical and Biotechnology Companies
  • 5.3 Academic & Research Institutes
  • 5.4 Others

6 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Shotgun Sequencing
  • 6.3 Targeted Gene Sequencing
  • 6.4 RNA Sequencing
  • 6.5 Whole Genome Sequencing
  • 6.6 Others

7 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY

  • 7.1 Overview
  • 7.2 Sequencing by Synthesis (SBS)
  • 7.3 Sequencing by Ligation (SBL)
  • 7.4 Pyrosequencing
  • 7.5 Sanger Sequencing
  • 7.6 Others

8 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY LABORATORY TYPE

  • 8.1 Overview
  • 8.2 Wet Labs
  • 8.3 Dry Labs

9 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY RESEARCH TYPE

  • 9.1 Overview
  • 9.1 Outsourced
  • 9.2 Internal

10 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET, BY GEOGRAPHY

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 U.K.
    • 10.3.3 France
    • 10.3.4 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
  • 10.6 Rest of the World
    • 10.6.1. Latin America
    • 10.6.2. Middle East & Africa

11 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET COMPETITIVE LANDSCAPE

  • 11.1 Overview
  • 11.2 Company Market Share
  • 11.3 Vendor Landscape
  • 11.4 Key Development Strategies

12 COMPANY PROFILES

  • 12.1 Charles River Laboratories
    • 12.1.1 Overview
    • 12.1.2 Financial Performance
    • 12.1.3 Product Outlook
    • 12.1.4 Key Developments
  • 12.2 Eurofins Scientific
    • 12.2.1 Overview
    • 12.2.2 Financial Performance
    • 12.2.3 Product Outlook
    • 12.2.4 Key Developments
  • 12.3 BGI
    • 12.3.1 Overview
    • 12.3.2 Financial Performance
    • 12.3.3 Product Outlook
    • 12.3.4 Key Developments
  • 12.4 CosmosID
    • 12.4.1 Overview
    • 12.4.2 Financial Performance
    • 12.4.3 Product Outlook
    • 12.4.4 Key Developments
  • 12.5 Microba
    • 12.5.1 Overview
    • 12.5.2 Financial Performance
    • 12.5.3 Product Outlook
    • 12.5.4 Key Developments
  • 12.6 QIAGEN
    • 12.6.1 Overview
    • 12.6.2 Financial Performance
    • 12.6.3 Product Outlook
    • 12.6.4 Key Developments
  • 12.7 Microbiome Insights
    • 12.7.1 Overview
    • 12.7.2 Financial Performance
    • 12.7.3 Product Outlook
    • 12.7.4 Key Developments
  • 12.8 BaseClear
    • 12.8.1 Overview
    • 12.8.2 Financial Performance
    • 12.8.3 Product Outlook
    • 12.8.4 Key Developments
  • 12.9 CD Genomics
    • 12.9.1 Overview
    • 12.9.2 Financial Performance
    • 12.9.3 Product Outlook
    • 12.9.4 Key Developments
  • 12.10 Zymo Research
    • 12.10.1 Overview
    • 12.10.2 Financial Performance
    • 12.10.3 Product Outlook
    • 12.10.4 Key Developments

13 KEY DEVELOPMENTS

  • 13.1 Product Launches/Developments
  • 13.2 Mergers and Acquisitions
  • 13.3 Business Expansions
  • 13.4 Partnerships and Collaborations

14 Appendix

  • 14.1 Related Research